Moreover, these genes have the potential to act as prognostic indicators, providing insights into disease progression and patient outcomes, with elevated levels of CXCL10 in RA, for example, linked to osteoclast formation and disease severity. This evidence concerns the gene CXCL10 and rheumatoid arthritis.